With the new MDR’s coming closer it becomes urgent for companies present in the EU market to sort all matter of distribution issues. The EU distinguishes several levels of economic actors: the Manufacturer, the Authorized Representative, the Importer and the Distributor, and each of these actors is now referred to in the Regulations. In this Read More …
Category: Method of Entry
MedTech Manufacturers, EU Distribution: Authorized Representative Agreements (Part 1).
With the new MDR’s coming closer it becomes urgent for companies present on the EU market to sort all matter of distribution issues. The EU distinguishes several levels of Economic Operators: Manufacturer, Authorized Representative (AR), Importer and Distributor. In this first article we will review the role of the Authorized Representative. The Authorized Representative Read More …
GB5D and SciMed Partners Announce Agreement to Collaborate
GB5D helps Companies Expand beyond Their Domestic Market The World Just Got a Little Bit Smaller SciMed Partners and GB5D have agreed to cooperate in order to better help foreign life sciences, medtech, and healthcare technology companies with US market entry. With several hundred years of combined biotech, medtech, life sciences, healthcare technology and international business Read More …
Milken NTE101: Mentoring Businesses Successful Domestically but New to Export.
The Milken Institute’s California Center recently launched a program called New to Export 101. The Milken NTE101 program aims to help local manufacturers who have a domestic market but are new to export. I volunteer as a Mentor. Any local manufacturer with an established domestic market and New to Export can apply to the program, Read More …
Should US MedTech companies be concerned about the new EU Medical Device Regulations?
The EU market has always been attractive for US MedTech companies. Obtaining approval to sell into the EU market has in the past always been easier than getting approval to sell in the US. That may soon change in view of the new EU Medical Device Regulations. For a long time, US manufacturers preferred to Read More …
Hurdles facing European MedTech companies wanting to enter the US Medical Device market.
Last week I visited the Medica show in Dusseldorf, Germany, the world’s biggest medical devices trade fair. 120,000 professional visitors from over 130 different countries met with more than 5,000 companies. I spend four days meeting with European MedTech companies that didn’t have a presence in the US market. I wanted to know why they Read More …
European Startups Set Up Shop in the US to Access American Venture Capital
Sometimes startups in Europe exhaust their access to local capital. They must consider moving to the US, or setting up a subsidiary in order to Access American Venture Capital. As an added benefit, European startups funded with US capital typically attain higher valuations than startups that only attracted European money. The US has more VC money than Europe. Per Read More …
Three Steps to Find your International Business Partner: 1. Develop the Ideal International Partner Profile for an Agent or Distributor
Many companies that are interested in exporting into an overseas market, are not ready to set up a subsidiary. They then have to choose between an indirect export method, using an export company, or a direct export method, using an International Partner such as a distributor or an agent. Let us presume that your company Read More …
Global Business Development as International Change Management
Your International Business Development Plan calls for the establishment of a first overseas subsidiary. It helps to look at the implementation of your plan as an “International Change Management” process. Your product development group will need input from your prospective overseas customers, and the shipping department needs to put new processes in place to ship to Read More …
Considering Global Growth? Get Expert Help
A Washington Post article written by UPS, Considering Global Growth? Try domestic expansion first, suggests that companies interested in growth dive deeper into domestic markets first. The article quotes Robert Eberhardt, assistant professor of management at Santa Clara University’s Leavey School of Business, who said “The research is fairly clear that, generally speaking, companies do Read More …